Showing posts with label Medication. Show all posts
Showing posts with label Medication. Show all posts

May 28, 2011

Saturday, May 28, 2011
A great deal of research boasts about the benefits of omega 3 fatty acids found in fish oil supplements. Now researchers at the Indiana University School of Medicine have found that it could also be beneficial in treating alcoholism and psychiatric disorders.
“In a multi-year study, researchers showed conclusive behavioral and molecular benefits for omega 3 fatty acid given to mice models of bipolar disorder. The fatty acid DHA, which is one of the main active ingredients in fish oil, "normalized their behavior," according to Alexander B. Niculescu, M.D., Ph.D., associate professor of psychiatry and the lead author of the study reported online in the Nature Publishing Group journal Translational Psychiatry.”
Researchers were able to draw such conclusions by studying the effects of Docosahexaenoic acid (DHA) on mice with characteristic bipolar symptoms including depression and manic episodes when exposed to stress.

Results showed that DHA normalized the behavior of the mice as they showed no signs of depression and experienced no periods of mania when under stress. Furthermore, molecular changes in their brain resulting from DHA correlate with molecular markers found in the blood, suggesting that DHA works similarly to psychiatric medications in the brain. According to Dr. Niculescu, "with these biomarker findings, we can now move forward as a field and do more targeted clinical studies in humans".

In addition, while studying the effects of DHA on the brain, researchers discovered that mice given DHA had less desire for alcohol.
“'These bipolar mice, like some bipolar patients, love alcohol. The mice on DHA drank much less; it curtailed their alcohol abusive behavior,' he said, adding that this is a completely novel finding. To verify this finding, the researchers studied another well-established animal model of alcoholism, the alcohol preferring P rats, and obtained similar results.”
Perhaps fish oil supplements may soon be used to treat bipolar disorder and alcoholism either exclusively or in conjunction with other treatment methods, thereby reducing unpleasant side effects of psychiatric medications while potentially improving overall health.

Fish Oil May Have Positive Effects on Mood, Alcohol Craving, New Study Shows

© www.mentalhealthblog.com

May 1, 2010

Saturday, May 01, 2010
Contrary to popular belief, risks associated with alcohol consumption do not only strike the young. “A new study by researchers at the David Geffen School of Medicine at UCLA has found that more than a third of drinkers 60 years old and older consume amounts of alcohol that are excessive or that are potentially harmful in combination with certain diseases they may have or medications they may be taking.”

Researchers studied data from 3,308 older patients from primary care clinics in and around Santa Barbara, California. However, the sample used is more likely to be white, married, well-educated with high income. In addition, findings are based on self-reports, which also weakens the validity of this study.

Despite a clear lack of generalizability and reliability, researchers have found that the risk associated with drinking in older adults who already have certain illnesses or take medications while consuming alcohol are just as numerous as those at risk from alcohol consumption alone.

The Comorbidity Alcohol Risk Evaluation Tool (CARET) was used to assess drinking habits among these older adults. Results determined whether they were considered to be at risk if they fell into any of the following categories:
  • more than 2 drinks consumed on most days of the week

  • one to two drinks consumed on most days in combination with other illnesses like gout, hepatitis or nausea

  • one to two drinks consumed on most days in combination with medications, such as antidepressants or sedatives
The specific findings include:
  • 34.7 percent (1,147) of older adults were at risk due to drinking alone or to drinking in combination with comorbidities or medications, and 19.5 percent fell into multiple risk categories.

  • Of those at risk, 56.1 percent fell into at least two risk categories, and 31 percent fell into all three.

  • Participants who had not graduated from high school had 2.5 times the odds of at-risk drinking as those who had completed graduate school.

  • Respondents with annual household incomes between $80,000 and $100,000 had 1.5 times the odds of being at-risk as those with incomes under $30,000.

  • Respondents who were 80 or older had half the odds of at-risk drinking as those between the ages of 60 and 64.

  • Asians had less than half the odds of at-risk drinking as Caucasians.
Results must be taken with a grain of salt when applying them to the general population as a 62-year-old married white male with a high annual household income cannot compare to an 85-year-old widowed Asian female with a low an annual income. The study also makes no mention of drinking habits prior to older age.

Regardless of the various inconsistencies, results do suggest that Physicians may need to pay more attention to the drinking habits of certain older adults and any possible interactions that may exist between alcohol consumption and other illnesses or medications since this study has shown that as many as one in three older adults in this study’s sample that continue to drink into older adulthood are more at risk.

High Rates of at-Risk Drinking Among Elderly Adults, Study Finds

© www.mentalhealthblog.com

November 7, 2009

Saturday, November 07, 2009
The recent tragedy in Fort Hood illustrates the dire need for mental health professionals in the military. “More than two years after the nation's political and military leaders pledged to improve mental-health care, their promises have fallen short at military hospitals around the country, according to mental-health professionals, Army officials, and wounded soldiers and their families.”

This deficiency in staffing escalates all the way the very top where Ellen Embrey can be found temporarily fulfilling the position of assistant secretary of defense for health affairs. Many of her colleagues seem to lack confidence in her ability to improve health care in the military.

In addition, the principal deputy, the deputy for clinical programs and policy, and the chief financial officer post are currently vacant. These vacancies clearly need to be filled as the suicide rate among soldier continues to increase. So far there have been 117 soldiers that have committed suicide this year; already an increase from last year’s total of 103 soldiers.

Despite the clear shortage of appropriate professionals managing the health care in the military, the Pentagon press secretary, Geoff Morrell, insists that more assistance is being offered than ever before. The problem lies in the way in which this help is communicated to those in need.

“Some 34,000 soldiers have been diagnosed with post-traumatic stress disorder since 2003, according to the Army surgeon general's office.” The amount of attention given to the mental health of soldiers has certainly increased since the Walter Reed scandal, where a series of allegations against the facility had been made because of unsatisfactory conditions and management.

Since then, the number of mental health professionals are said to have increased as well. According to the Washington Post, “200 behavioral-health personnel are deployed in Iraq and 30 in Afghanistan. The military has also hired 250 additional behavioral-health providers and more than 40 marriage and family therapists in recent months. The Army currently has 408 psychiatrists for its force of 545,000 people.” Walter Reed Army Medical Center, the facility that interned Major Nidal Malik Hasan, has increased their staff by 35% since 2007. That being said, do the numbers add up? Is there sufficient mental health staff available to treat 34,000+ soldiers with PTSD, not to mention the soldiers that may be dealing with other types of mental illness?

Due to such a shortage, many patients are stuck with whatever service they can get. Joe Wilson, a former social worker at Walter Reed, claims that soldiers have no choice but to stick with the psychiatrist they’ve been appointed because a switch could only make matters worse by delaying the determination of whether a soldier should remain in the service or not. This could force patients to keep quiet about poor or unsatisfactory service out of fear they may be deployed.

Not only are patient/doctor relationships somewhat of a dilemma, but many soldiers may have no choice but to accept pharmaceutical treatment because of the persistent shortage of mental health professionals available to treat the military. This leaves most soldiers with post traumatic stress disorder to be treated with medication such as sleeping pills and mood-altering drugs instead of one-on-one therapy.
The wife of an amputee soldier recovering at Walter Reed with traumatic brain injury and PTSD said that mental-health services are so uncoordinated and ineffective that the couple decided to pay for private psychotherapy sessions with a civilian provider at $130 an hour.

The couple sought private treatment elsewhere after spending a few minutes with a Walter Reed psychiatrist, who then referred the soldier to a social worker for treatment.

"It was a joke," said the wife, who asked not be identified because her husband, a sergeant, is still recovering at Walter Reed. "She was a lovely person, but we have a serious problem here and she just didn't get it . . . She essentially directed me to a Web site."
Many soldiers with mental illness may feel ignored in comparison to physically wounded soldiers. Sophia Taylor, a patient at Walter Reed that is currently being processed for dishonorable discharge, claims that amputees get treated, but those with mental illness lack appropriate treatment. “I have a lot of respect for them. But I lost my mind, and I couldn't even get a simple 'thank you for your service.' "

At Walter Reed, a palpable strain on mental-health system

© www.mentalhealthblog.com

February 20, 2009

Friday, February 20, 2009
The current issue of The Journal of Pain has published a guideline to assist clinicians in prescribing opioid pain medications for patients experiencing chronic non-cancer pain.

“To create this guideline, researchers in the Oregon Evidence-based Practice Center (EPC) at Oregon Health & Science University collaborated with the APS and AAPM for two years, reviewing more than 8,000 published abstracts and nonpublished studies to assess clinical evidence on which the new recommendations are based”.

An extensive literature review revealed that much research is needed in this area; however conclusive evidence suggests that opioids are safe and effective for certain patients, if carefully monitored.

The guideline consists of 25 recommendations, some of which consider the growing concerns for opioid abuse and addiction. Opioids, such as oxycontin and morphine, have gradually become more commonly prescribed and accepted for treating various sorts of pain, including chronic low-back pain, arthritis, fibromyalgia etc., whereas previously opioids were mainly used for treating pain related to post-op, cancer and death.

This new guideline insists that clinicians rule out other possible medications as treatment options before prescribing opioids. However, if it is determined that opioid medication is the ideal choice, clinicians are expected to “conduct a thorough medical history and examination and assess potential risk for substance abuse, misuse or addiction”.

It is shocking to learn that this hasn’t already been considered common practice and that a guideline had to be introduced in order to put this in place! It’s no wonder there has been such an increase in opioid abuse and misuse. Seriously, is this not a typical task for a medical doctor? It seems like a fairly important step in any type of treatment.

Subsequently, with this guideline it will ensure that clinicians “continuously assess patients on chronic opioid therapy by monitoring pain intensity, level of functioning and adherence to prescribed treatments. Periodic drug screens should be ordered for patients at risk for aberrant drug behavior”.

The American Pain Society and the American Academy of Pain Medicine have ensured that patients will be well monitored. To read more about other recommendations in this guideline regarding such topics as methadone use, high dosages, abusers, pregnancy, driving safety, and more, please view the following article: New Guideline For Prescribing Opioid Pain Drugs.

© www.mentalhealthblog.com

September 22, 2008

Monday, September 22, 2008
"Service Nova Scotia now requires people renewing their licences to indicate on an application form if they’ve had a 'psychiatric or psychological condition'". If the answer to that question is yes, Nova Scotians' are required to provide more in depth information including medical information that is usually kept in strict confidentiality. This medical information is reviewed by provincial government staff and, if necessary, cases can be referred to a committee of specialists to make recommendations on whether the individual is mentally capable of driving. The application also inquires about any history of lung, heart, eye or neurological diseases. Obviously, doctors can charge a fee for this application and without it people run a risk of losing their licence.

Thankfully, Service Nova Scotia has withdrawn this new form, for now, claiming that the "department failed to check the appropriateness of the wording before putting the new forms into use." Instead, Dulcie McCallum, Nova Scotia's freedom of information and protection of privacy review officer, states that "it would be more appropriate to ask if people were taking any prescription medication that could affect their driving". "That doesn’t connect it to any particular illness or disability or historically disadvantaged group and it may be a bona fide question", she continues. Now, this does not sound like the idea has been completely rejected. In fact, the renewal process still asks whether one has a mental or physical disability that may prevent them from properly operating a motor vehicle and depending on one's response, more detailed information could be requested.

Typically, people come to the realisation that they are no longer able to drive on their own; however Nova Scotia has decided that the government must decide when an individual is no longer mentally fit for driving. Paul Arsenault of the provincial registrar of motor vehicles insists that this is important for public safety.

Granted, prescription medication is being prescribed in record doses, but as far as I know, doctors still have a legal obligation to report whether someone is no longer capable of operating a motor vehicle? Or do they? Apparently, Nova Scotia's doctors are not bound by law to report such cases. Should this not be a more appropriate angle, especially since doctors already have the power to prescribe and have total access to a medical history? It seems more than ridiculous to expect government bureaucrats to police the province’s drivers. What’s next? Are government employees going to start patrolling for drunk drivers too?

David Simpson, an Ontario rights advocate of the Mental Health Police Records Coalition explains that "what you always have to be worried about in situations like this is if there is some sort of systemic bias in place or covert discrimination, that they believe because you have a mental illness you’re going to use your vehicle as a weapon to injure people or injure yourself." What about people busy texting, eating, chatting on their cell phone, fiddling with their blackberry, or operating their GPS?

Furthermore, how long would it be before people with high blood pressure and risk of heart attack or stroke lose their licence as well? We can only hope this line of
thinking doesn’t make its way into Ontario.

Government cancels form asking drivers about mental health
Critics: Don’t tie driver’s licence renewal to psychiatric history

POLL RESULTS:

Should one's mental health be considered when issuing a driver's licence?

38% - YES

61% - NO

© www.mentalhealthblog.com

May 27, 2008

Tuesday, May 27, 2008

New research suggests that religious leaders may have been sitting on a potential treatment for depression all along. Even hippies seem to have caught on to the healing powers of incense long before the academic world.

A team of researchers from John Hopkins University and the Hebrew University in Jerusalem studied the psychoactive effects of burning incense. Researcher, Raphael Mechoulam "found that incensole acetate, a Boswellia resin constituent, when tested in mice lowers anxiety and causes antidepressive-like behavior". Specifically, this constituent activates the TRPV3 protein in areas of the brain that are associated with emotions and nerves. These areas are the same as those already being activated by current medication in use for the treatment of depression and anxiety. Evidently, mice bred without this protein were not affected by the incense.

Although, the idea seems rather harmless in comparison to many of the medications on the market at this time, I have to wonder whether or not this might be a better alternative to medication. I am not convinced that this treatment holds much weight when considering the possible health risks associated with daily doses of incense inhalation in order to sufficiently reduce anxiety and depression.

© www.mentalhealthblog.com

April 13, 2008

Sunday, April 13, 2008
The British Journal of Psychiatry presented a study conducted by Yale School of Medicine regarding the tendency to extract a meaningful message from meaningless noise. The study implies that, over time, this ability could produce a 'matrix of unreality' that triggers the initial psychotic phase of schizophrenia-spectrum disorders. The study implies that this ability could be an early sign of schizophrenia.

The study consisted of a measly 43 participants who had already been diagnosed with prodromal symptoms such as social withdrawal, mild perceptual alterations or misinterpretation of social cues.

A medication called olanzapine was used in this study. It is also known as zyprexa, an atypical antipsychotic used to treat schizophrenia and bipolar disorder. Participants were assessed for up to two years after being randomly assigned to either this medication or a placebo.

The participants listened to a reading of a text through headphones, but this text was read by six different people at the same time. The overlap of the words made comprehension virtually impossible. The only words detected with any kind of consistency were increase, children, A-OK, and Republican.

"Eighty percent of the participants who 'heard' phrases of four or more words in length went on to develop a schizophrenia-related illness during times that they were not taking olanzapine, said the lead author, Ralph Hoffman, M.D., associate professor of psychiatry. In contrast, only six percent of those in the study converted to schizophrenia-related illness if the phrases 'heard' were less than three words in length." – Article

Clearly this is not sufficient research to conclusively report the effectiveness of this type of screening tool, but it’s an interesting attempt. How long could it be until we are using simple white noise to render a diagnosis.



Detect anything meaningful?

© www.mentalhealthblog.com

April 11, 2008

Friday, April 11, 2008
As promised, here are some brief excerpts from my paper regarding the treatment of trichotillomania. This is simply a follow-up to the previous post: Assessment of Trichotillomania.

"Trichotillomania typically presents many challenges to effective treatment. The extant literature suggests that a minority of patients respond to a single intervention, for example, habit reversal or a specific pharmacological agent" (Christenson, Hollander & Stein, 1999, p. 93). Following careful investigation of data pertaining to treatment, findings point toward a high need for long-term controlled studies in order to determine the most appropriate methods for treating trichotillomania. The current research implies that there is no explicit procedure designed to be effective in all cases, rather because individuals have responded differently to various treatments and since studies have produced varied results, the ideal treatment could be some combination of techniques dependent on the individual. Because of this lack in concrete evidence to support the most successful method; this paper will explore the most effective treatment modalities currently in place. Accordingly, the existing appropriate methods are behavioural and pharmacotherapy or some combination of the two. There have been numerous techniques employed over the years; therefore a short review of these other methods will also be presented. [...]

Basically, in some form or another, HRT models consist of the following components: competing reaction training, awareness training, identifying response precursors, identifying habit prone situations, relaxation training, prevention training, habit interruption, positive attention (overcorrection), competing reaction, self-recording, display of improvement, social support and annoyance review (Christenson et al., 1999, p. 156). "Habit reversal training remains the most widely accepted treatment with the most convincing documentation of its efficacy" (Christenson et al., 1999, p. 161). [...]

Similar to behavioural treatment, pharmacotherapy has very little research to confidently support the most useful medications (Christenson et al., 1999, p. 171). Consequently, there has been a great deal of disagreement regarding the most effective medication to treat trichotillomania (Kelly et al., 2004, p. 5). That being said, there have been a multitude of medications prescribed over the years in an attempt to uncover the most effective drug. There is significant variability among medications due to the wide range of the disorder’s symptoms and the lack of long-term studies (Christenson et al., 1999, p. 96). [...]

"Treatment studies are plagued with conflicting results, a lack of large-scale controlled treatment trials, and limited long-term follow-up of patients" (Baer et al., 1998, p. 561). Because of this deficiency in terms of concrete support for the most effective method to treat trichotillomania; this paper has focused on exploring the most successful modalities presently in place. Therefore, behavioural and pharmacotherapy or some combination of the two have been considered as the most appropriate methods of treatment. Specifically, habit reversal treatment has proven to be the most successful form of behavioural treatment, while anti-depressants have been considered the most reliable medications currently being prescribed. In summary, thorough investigation has revealed a critical need for additional research of treatment modalities in order to ensure that the most effective methods are being applied in treating trichotillomania.

© www.mentalhealthblog.com

January 28, 2008

Monday, January 28, 2008
Although the idea of treating epilepsy through diet is not a novel one, recent studies with adults have demonstrated some valuable results. Epileptic children have benefited from following the ketogenic diet for many years. This diet is one consisting of fasting and very restricted amounts of fluids and carbohydrates. It works so well that it can even completely eliminate seizures in children. The diet builds up ketones or compounds in the body that are produced mostly from fat calories.

The secret to this science remains unknown to date; however, recent research suggests that a similar diet could be a saving grace for epileptic adults who are unable to benefit from medication.

In 2002, John Hopkins began research with a modified version of the Atkins diet, which did not have a fasting component nor a restricted fluid or carb intake. The diet consisted of about 15 grams of carbohydrates. Research proved to be beneficial for children so they turned to adults. What was found?

Those who had been suffering on average 10 seizures per week had vastly reduced their episodes. After only 1 month half displayed a 50% reduction in seizures and after 3 months, one third had reduced their seizures to half. Nevertheless, roughly one third had to quit the diet after 3 months due to an inability to follow the regimen. Fortunately, side affects appeared to be minimal. Although, I feel that more studies are needed to test long-term affects of such a restricted diet.

Most striking is that fourteen of those in the study chose to continue this alternate form of treatment beyond the 6 month trial proving that, although not everyone will benefit from or stomach this type of diet, for some it could be a way of life for those forced to make the choice between medication, surgery and electrical stimulation.

Full Article

© www.mentalhealthblog.com

Popular Posts

Dentalget.com is dental equipment supplier, we provide high quality dental instruments, dental handpiece at a discount price. Free shipping worldwide.

Categories

9/11 AADD Abortion Academic Success Acetylcholine ADD Adderall Addiction ADHD Adult Attention Deficit Disorder Adultery Advertising Aggression Aging Agreeableness AIDS Air Pressure Alcohol Alcohol Abuse Alcohol Dependence Alcoholism alpha-CaM kinase II Altitude Alzheimer's Amphetamine Amygdala Amyloid Amyloid Deposition Anesthesia Anger Anterior Cingulate Cortex Anterograde Amnesia Anti-Depressants Anti-Psychotic Anticholinergic Anticonvulsant Antiepileptic Antioxidants Anxiety Anxious-Avoidant Anxious-Preoccupied Apolipoprotein E Army Aromatherapy Asperger Syndrome Assessment Associative Learning Asthma Attachment Theory Attention Attention Deficit Disorder Attention Deficit Hyperactivity Disorder Autism Autism Spectrum Disorder Autonomic Nervous System Average Sleep Requirements B-type Natriuretic Peptide Babies Balance Behavioral Problems Behaviour Behavioural Impairment Behavioural Therapy Benadryl Bipolar Disorder Blood Clot Blood Pressure Blue Light Blue Light Goggles Body Mass Index Bone Marrow Brain Brain Development Brain Imaging Brain Injury Brain Stem Brain Surgery Breast Cancer Buddhism bullying Bupropion Business C-reactive Protein Calories CAMH Canada Canadian Charter of Rights and Freedoms Cancer Carbohydrates Cardiovascular Disease Care Facilities Caregiver cars Cdk5 Cell Phone Central Nervous System Centre for Addiction and Mental Health Cerebellum Cerebral Amyloid Angiopathy Cerebral Cortex Cerebrospinal Fluid Cerebrovascular Accident Cerebrovascular Insult Chat Rooms Chewing Childhood Disabilities Childhood Disintegrative Disorder Childhood Emotional Neglect Children Chitin Chitosan Cholesterol Choline Chromosome Chronic Pain Syndrome Chronic Stress Circadian Rhythm Cirrhosis Citalopram Classical Conditioning Climate Change Clot-Busting Drug Co-morbidity Cocaine Cognition Cognitive Development Cognitive Impairment Colloquially Brain Attack Coma Communication Device Communication Technology Concentration Concerta Concussion Conflict Confusion Conscientiousness Control Group Coordination Correlation Cortisol Counselling Couples CPAP Crack CRASH-2 CRASH-3 Creativity Criminal Code Cyberbullying Cyberpsychology Cyklokapron Daytrana Death Death Toll Decision-Making Declarative Memory Deep Brain Stimulation Delusion Dementia Dentures Depression Destrostat Deviant Behaviour Dexedrine Dextromethorphan Diabetes Diet Dietary Supplements Diphenhydramine Disability discrimination Dismissive-Avoidant Disorganized Attachment Disorganized Speech Disorientation Dizziness Docosahexaenoic Acid (DHA) Double-Blind Dream Drinking Drowsiness Drug Abuse Drug Dependence Drug Use Drugs DSM DSM-5 Dual Diagnosis Early Onset Alzheimer's Economic Crisis Ecstasy Effexor Ego Eicosapentaenoic Acid (EPA) Elderly Electrical Stimulation Electroconvulsive Therapy Electrodes Email Embitterment Embolic Emotion Emotional Neglect Emotional Problems Emotional Well-Being Employee Enrivonment Enzyme Epilepsy Estrogen Ethics Evolution Experimental Group Extracellular Signal-Regulated Kinase (ERK) Extroversion Facebook Facebook Fan Page Facebook Friends Family Family Therapy Fast Food Father Father Absenteeism Fatherhood FDA Fear Fearful-Avoidant FeelingBetterNow Fetus Fibrin Fish Oil fluoxetine fMRI Focalin Focus Food Fraud Friday Gamma Secretase Genetic Disorders Genetics Ginkgo Biloba Glucose Glutamate Receptor God Gout Guest Blogger Hair Pulling Haiti Hallucination Hallucinogenic Halo Effect Harm-Reduction Headache Healthy Eating Hearing Heart Attack Heart Disease Hematopoietic Stem Cells Hepatitis Hepatitis C Herbal Supplements Hereditary Angioedema Heredity Heroin High Blood Pressure Hippocampus Hockey Homelessness Hormone Housing Hox Genes Hoxb8 Cells Human Rights Hydromorphone Hyper-social Networker Hyperactivity Hypothalamus Illness Impulse Control Impulsivity Inattentiveness Infant Infidelity Inflammation Insecure Attachment Insomnia Instant Messaging Insulin Intellectual Development Intellectual Disability Internet Intracranial Bleeding Introversion Introvert Ischemic Stroke KASPAR Ketamine Ketogenic Kleptomania Laptop Latent Inhibition Learning Learning Disability Leukotrienes Limbic System Lithium Liver Locked-In Syndrome Long Term Memory Long-Term Potentiation Longevity Lupus Lysteda Maestro Rechargeable System Major Depression Mania MAOI Marriage MDMA Medication Meditation Melatonin Memory Memory Loss Memory Task Men Mental Health Mental Health Forum Mental Heath Mental Illness Metadate Metyrapone Mice Microglia Mild Cognitive Impairment (MCI) Mild Traumatic Brain Injury Military Mind-Body Mindless Eating Mitochondria MOHLTC Mood Disorder Morphine Mortality Rates MRI MS-275 Multiple Sclerosis Muscle Weakness music therapy Narcissism Natasha Richardson National Sleep Foundation Natural Disaster Nature/Nurture Nausea Necrosis Neglect Nerve Neuro-imaging Neurobiology Neurodegeneration Neurodegenrative Diseases Neurodevelopment Disorders Neurogenesis Neurological Disease Neuromarketing Neuron Neuropathy Neuroticism Neurotransmitter News Nintendo Wii Non-REM Sleep Nose Nurse Ratched Nutrition Obesity Obessive Compulsive Spectrum Disorder (OCD) Offspring Olfactory Gland OM3 Emotional Balance Omega 3 Ontario Ontario Review Board Ontario Works Opioid Oral Health Organic Ottawa Over-activity Over-Medication Ovulation Oxidative Cell Oxygen Oxytocin p35 Pacemaker Pain Pain Killer Pain Management Pancreatic Polypeptide Pancreatitis Paralysis Paranoia Paraskevidekatriaphobia Parenthood Parents Parkinson's Paroxetine Paxil PDD-NOS perception Perfume Peripheral Nervous System Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Pathway personality traits Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) PET Scan Pharmacology Phobias Physical Health Physiological Plasmin Plasminogen Plasticity Platelet-Activating Factor Politics Post-Concussion Assessment and Cognitive Test (ImPACT) Potassium Ion Channel Poverty Pregnancy Pressure Procedural Memory Promiscuity Prozac PsychBoard.com Psychiatric Ward Psychological Psychological Inventories Psychologist Psychology Psychology Forum Psychology of Eating Psychosis PTED PTSD Public Health Pyromania Quadriplegic Rehab Relationships Reliability Religion REM Research Retigabine Retrograde Amnesia Rett Syndrome Risperdal Ritalin road rage Robot Robotics Rodent Research Rosiglitazone Samsung Satiety Scales Schizophrenia School Screening Secure Attachment Sedatives Seizure Self-Affirmation Intervention Self-Confidence Self-Esteem Self-Integrity Self-Worth Semantic Memory Senior Seroquel Serotonin Serzone Sex Sex Therapy Sexual Orientation Sexual Satisfaction Shock Therapy Sideline Concussion Assessment Test (SCAT2) Sleep Sleep Apnea Sleep Disorders Sleep Quality Sleep Stages Smartphone Smoking Snacking Sniffing Technology Social Assistance Social Deficits Social Isolation Social Media Social Network Social Rejection Social Skills Social Worker Socialization Societal Change Soft Palate Soldier Somatic Nervous System Spatial Memory Special K Speech Spinal Cord Spinal Cord Injury Spinal Tap Sports Injury SSRI Statin Stem Cell Stimulant Strattera Stress Stress Hormone Stroke Substance Abuse Sugar Suicide Superstition Support Survey Suspicious Tablet Talk Therapy Tamoxifen Tanorexia Tax Payer Technology Television Telomere Temperature Testosterone Texting Therapy Thorazine Threshold Thrombosis Thrombotic Tinnitus Tissue Plasminogen Activator Topographical Disorientation Tranexamic Acid Trauma Treatment Tremors Trial Tribunal Trichotillomania Type-2 Diabetes Vagus Nerve Validity Ventromedial Prefrontal Cortex Video Games Virtual Reality Vision Visual Attention Vitamin B Vitamins Vitiligo Voice Vyvanse Walnuts Weight Loss Welfare Wellbutrin Wernicke–Korsakoff syndrome Wet Brain White Blood Cells Women Work World Health Organization Zileuton Zyban Zyprexa µ-opiate receptors (MOR)